Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Retinoids may help treat lupus nephritis and reduce steroid use.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Topical finasteride is an effective and safer treatment for male hair loss.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Karunjchirakam Chooranam significantly improved symptoms in most PCOS cases.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Clascoterone safely promotes hair growth similar to minoxidil.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.